Dasatinib

Results: 118



#Item
101The CML Guide Information for Patients and Caregivers Chronic Myeloid Leukemia Matthew, CML survivor

The CML Guide Information for Patients and Caregivers Chronic Myeloid Leukemia Matthew, CML survivor

Add to Reading List

Source URL: www.lls.org

Language: English - Date: 2012-05-29 13:27:29
1022849 Analysis of the cancer gene targeting of clinical kinase inhibitor drugs by combining cellular and biochemical profiling Joost C.M. Uitdehaag , Jeroen A.D.M. de Roos , Antoon M. van Doornmalen , Martine B.W. Prinsen

2849 Analysis of the cancer gene targeting of clinical kinase inhibitor drugs by combining cellular and biochemical profiling Joost C.M. Uitdehaag , Jeroen A.D.M. de Roos , Antoon M. van Doornmalen , Martine B.W. Prinsen

Add to Reading List

Source URL: www.carnabio.com

Language: English - Date: 2014-04-16 07:09:16
103Dasatinib（星野先生）.indd

Dasatinib（星野先生）.indd

Add to Reading List

Source URL: www.medicalfront.biz

Language: Japanese - Date: 2013-02-27 07:17:32
    104OTT[removed]profile-of-bosutinib-and-its-clinical-potential-in-the-treat

    OTT[removed]profile-of-bosutinib-and-its-clinical-potential-in-the-treat

    Add to Reading List

    Source URL: www.ncbi.nlm.nih.gov

    Language: English
    105FOP ACTION AGENDA • Update from FOP Research Team • Future research team structure and planned research • Research Grants and collaborative projects • Budget required by research team for following year

    FOP ACTION AGENDA • Update from FOP Research Team • Future research team structure and planned research • Research Grants and collaborative projects • Budget required by research team for following year

    Add to Reading List

    Source URL: www.fopaction.co.uk

    Language: English
    106Gene Therapy and Molecular Biology Vol 16, page 10 Gene Ther Mol Biol Vol 16, 10-29, 2014 Survival assessment and Optimization of BCR/ABL-KD

    Gene Therapy and Molecular Biology Vol 16, page 10 Gene Ther Mol Biol Vol 16, 10-29, 2014 Survival assessment and Optimization of BCR/ABL-KD

    Add to Reading List

    Source URL: www.gtmb.org

    Language: English - Date: 2014-04-08 07:34:01
    107HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG® (ponatinib) tablets for oral

    HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG® (ponatinib) tablets for oral

    Add to Reading List

    Source URL: s368855769.onlinehome.us

    Language: English - Date: 2014-02-10 09:17:42
    108Clinical characteristics and prognosis of osteosarcoma in young children: a retrospective series of 15 cases

    Clinical characteristics and prognosis of osteosarcoma in young children: a retrospective series of 15 cases

    Add to Reading List

    Source URL: www.ncbi.nlm.nih.gov

    Language: English
    109Letter to the Editor Diagnostic Hematology Ann Lab Med 2014;34:[removed]

    Letter to the Editor Diagnostic Hematology Ann Lab Med 2014;34:[removed]

    Add to Reading List

    Source URL: www.ncbi.nlm.nih.gov

    Language: English
    110ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

    ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

    Add to Reading List

    Source URL: www.ema.europa.eu

    Language: English - Date: 2014-04-10 11:40:36